Cis- and trans-regulations of pre-mRNA splicing by RNA editing enzymes influence cancer development

Area of Science:

• Molecular Biology
• Genetics
• Biochemistry

Background:

• RNA editing and splicing are key regulators of transcriptome diversity.
• The interplay between ADARs (RNA editing enzymes) and splicing is not fully understood, especially in cancer.

Purpose of the Study:

• To elucidate the mechanisms by which ADAR1 and ADAR2 influence RNA splicing.
• To investigate the biological significance of ADAR-regulated splicing in tumorigenesis.

Main Methods:

• Identification of ADAR-altered splicing events using high-confidence analysis.
• Characterization of ADAR binding to dsRNAs involving GA-rich sequences.
• Mechanistic studies on ADAR1-mediated splicing repression and ADAR2-mediated splice site blocking.

Main Results:

• Approximately 100 splicing events were found to be regulated by ADAR1 and/or ADAR2.
• ADARs bind to GA-rich dsRNAs, influencing both editing and splicing.
• ADAR1 represses exon inclusion by editing an intronic splicing silencer, while ADAR2 blocks spliceosome access.
• ADAR-regulated splicing alterations directly contribute to tumorigenesis.

Conclusions:

• ADARs directly modulate RNA splicing through distinct mechanisms.
• These splicing alterations are not mere byproducts but actively contribute to cancer development.
• Understanding ADAR-splicing crosstalk is crucial for cancer research and therapeutic strategies.